GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Gross Margin %

TCM Biotech International (ROCO:4169) Gross Margin % : 48.39% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. TCM Biotech International's Gross Profit for the six months ended in Dec. 2023 was NT$244.1 Mil. TCM Biotech International's Revenue for the six months ended in Dec. 2023 was NT$504.4 Mil. Therefore, TCM Biotech International's Gross Margin % for the quarter that ended in Dec. 2023 was 48.39%.


The historical rank and industry rank for TCM Biotech International's Gross Margin % or its related term are showing as below:

ROCO:4169' s Gross Margin % Range Over the Past 10 Years
Min: 35.42   Med: 48.14   Max: 55.89
Current: 49.52


During the past 13 years, the highest Gross Margin % of TCM Biotech International was 55.89%. The lowest was 35.42%. And the median was 48.14%.

ROCO:4169's Gross Margin % is ranked worse than
61.73% of 750 companies
in the Biotechnology industry
Industry Median: 60.53 vs ROCO:4169: 49.52

TCM Biotech International had a gross margin of 48.39% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for TCM Biotech International was 1.80% per year.


TCM Biotech International Gross Margin % Historical Data

The historical data trend for TCM Biotech International's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Gross Margin % Chart

TCM Biotech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.06 50.05 51.10 55.89 49.52

TCM Biotech International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.48 57.53 54.47 50.75 48.39

Competitive Comparison of TCM Biotech International's Gross Margin %

For the Biotechnology subindustry, TCM Biotech International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TCM Biotech International's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's Gross Margin % distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's Gross Margin % falls into.



TCM Biotech International Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

TCM Biotech International's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=480.2 / 969.619
=(Revenue - Cost of Goods Sold) / Revenue
=(969.619 - 489.451) / 969.619
=49.52 %

TCM Biotech International's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=244.1 / 504.385
=(Revenue - Cost of Goods Sold) / Revenue
=(504.385 - 260.31) / 504.385
=48.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


TCM Biotech International  (ROCO:4169) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

TCM Biotech International had a gross margin of 48.39% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


TCM Biotech International Gross Margin % Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


TCM Biotech International (ROCO:4169) Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines